UBS Starts BioAge Labs Inc (BIOA) at Neutral

October 12, 2026 2:23 AM EDT Send to a Friend
UBS analyst Alice Nettleton initiates coverage on BioAge Labs Inc (NASDAQ: BIOA) with a Neutral rating and a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login